Real-world study of tirzepatide for obesity
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial examines how well tirzepatide works for weight loss in people with obesity, and how it's actually used in daily life. It may be an option if you haven't tried other obesity treatments and don't have diabetes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have a BMI of 30 or higher, or a BMI of 27 or higher with an obesity-related condition like high blood pressure or high cholesterol
- You have never been treated for obesity with weight-loss medications, endoscopic procedures, or surgery
- You do not have diabetes
- If you are able to become pregnant, you are not pregnant and will not become pregnant during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if tirzepatide is more effective than standard obesity treatments for adults who have a BMI between 30 and 35 and one weight-related health condition, but do not have diabetes. The goal is to help you lose weight.
This study tests if tirzepatide helps people with obesity lose weight, whether or not they have type 2 diabetes. It aims to see how safe and effective the drug is.
This Phase 2 study tests whether tirzepatide can improve how your body handles fat (especially in people with overweight or obesity) and reduce fat-related “lipotoxicity.” It may help with body fat function and related health markers, but you must meet specific health and medication rules.
This trial tests a once-weekly injection called tirzepatide to see if it helps people with type 2 diabetes and obesity control their blood sugar and lose weight. The goal is to see how well it works and how satisfied patients are with this treatment.
This trial tests if tirzepatide, a weekly injection, can help people with type 1 diabetes who are also overweight or obese. The goal is to see if it improves blood sugar control and supports weight loss.
This trial tests the safety and effectiveness of tirzepatide, a once-weekly injection, for weight loss in people with obesity. It might be an option if you have a BMI of 27 or higher with weight-related health problems, or a BMI of 35 or higher, and live in or near Asunción, Paraguay.
Hear when a new Obesity (Disorder) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.